This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange rose 11.44 points to 766.20 Thursday. Ian Burns's halted capital pool shell, Montreux Capital Corp. (MRX), plans to acquire Colorado medical device company Assure Neuromonitoring LLC for the shell's qualifying transaction. The deal involves several steps. First, Montreux will roll back 1 for 2, leaving it with 4.18 million postconsolidated shares issued. Then, it will sell a private placement of five million postconsolidated shares at five cents. It will use the $250,000 proceeds to provide a bridge loan to Assure. Meanwhile, Assure will also raise $250,000 on its own, to finance its business while the QT is in progress. To this end, Assure will sell 1,666,666 shares at 15 cents. Next, Montreux will roll back again, this time 1 for 3, leaving it with 3.06 million postconsolidated shares issued. At this point, Assure will sell a $3-million private placement of shares at 50 cents to raise money for the resulting issuer. Finally, to acquire Assure, Montreux will issue between 25,666,666 and 33 million postconsolidated shares to Assure's shareholders. The resulting company, which will have between 28,726,666 and 36.06 million shares issued, will be an industrial issuer called Assure Holdings Corp.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS